DiscoverOncology Today with Dr Neil LoveData + Perspectives: Clinical Investigators Discuss the Role of CAR T-Cell Therapy for Patients with Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
Data + Perspectives: Clinical Investigators Discuss the Role of CAR T-Cell Therapy for Patients with Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

Data + Perspectives: Clinical Investigators Discuss the Role of CAR T-Cell Therapy for Patients with Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

Update: 2025-01-22
Share

Description

Dr Joshua Brody from the Tisch Cancer in New York, Dr Matthew Lunning from the University of Nebraska Medical Center in Omaha and Dr Jason Westin from the University of Texas MD Anderson Cancer Center in Houston discuss chimeric antigen receptor T-cell therapy for non-Hodgkin lymphoma and chronic lymphocytic leukemia. Produced by Research To Practice.

CME information and select publications here.

Comments 
loading
Top Podcasts
The Best New Comedy Podcast Right Now – June 2024The Best News Podcast Right Now – June 2024The Best New Business Podcast Right Now – June 2024The Best New Sports Podcast Right Now – June 2024The Best New True Crime Podcast Right Now – June 2024The Best New Joe Rogan Experience Podcast Right Now – June 20The Best New Dan Bongino Show Podcast Right Now – June 20The Best New Mark Levin Podcast – June 2024
In Channel
Data + Perspectives: Clinical Investigators Discuss the Role of CAR T-Cell Therapy for Patients with Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

Data + Perspectives: Clinical Investigators Discuss the Role of CAR T-Cell Therapy for Patients with Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

2025-01-2259:32

Oncology Q&A for Patients with Metastatic Triple-Negative Breast Cancer

Oncology Q&A for Patients with Metastatic Triple-Negative Breast Cancer

2025-01-1701:00:59

CAR T-Cell and Bispecific Therapy for Lymphoma — Part 3 of Our 6-Part ASH 2024 Friday Satellite Symposia Series

CAR T-Cell and Bispecific Therapy for Lymphoma — Part 3 of Our 6-Part ASH 2024 Friday Satellite Symposia Series

2025-01-1502:00:29

Myelofibrosis — Part 4 of Our 6-Part ASH 2024 Friday Satellite Symposia Series

Myelofibrosis — Part 4 of Our 6-Part ASH 2024 Friday Satellite Symposia Series

2025-01-1301:59:15

Metastatic Breast Cancer — San Antonio 2024 symposium series proceedings Part 3

Metastatic Breast Cancer — San Antonio 2024 symposium series proceedings Part 3

2025-01-1002:01:00

Chronic Myeloid Leukemia — Part 1 of Our 6-Part ASH 2024 Friday Satellite Symposia Series

Chronic Myeloid Leukemia — Part 1 of Our 6-Part ASH 2024 Friday Satellite Symposia Series

2025-01-0801:27:00

Acute Myeloid Leukemia — Part 5 of Our 6-Part ASH 2024 Friday Satellite Symposia Series

Acute Myeloid Leukemia — Part 5 of Our 6-Part ASH 2024 Friday Satellite Symposia Series

2025-01-0601:58:51

The Role of Endocrine-Based Therapy in the Management of Breast Cancer — San Antonio 2024 symposium series proceedings Part 2

The Role of Endocrine-Based Therapy in the Management of Breast Cancer — San Antonio 2024 symposium series proceedings Part 2

2025-01-0302:00:37

HER2-Low and HER2-Ultralow Breast Cancer — San Antonio 2024 symposium series proceedings Part 1

HER2-Low and HER2-Ultralow Breast Cancer — San Antonio 2024 symposium series proceedings Part 1

2024-12-2301:31:29

Multiple Myeloma — Part 6 of Our 6-Part ASH 2024 Friday Satellite Symposia Series

Multiple Myeloma — Part 6 of Our 6-Part ASH 2024 Friday Satellite Symposia Series

2024-12-2001:57:11

Chronic Lymphocytic Leukemia — Part 2 of Our 6-Part ASH 2024 Friday Satellite Symposia Series

Chronic Lymphocytic Leukemia — Part 2 of Our 6-Part ASH 2024 Friday Satellite Symposia Series

2024-12-1801:57:07

Cases from the Community: Integrating New Research Findings into Current Practice — Colorectal and Gastroesophageal Cancers

Cases from the Community: Integrating New Research Findings into Current Practice — Colorectal and Gastroesophageal Cancers

2024-12-1849:11

Cases from the Community: Integrating New Research Findings into Current Practice — Hepatobiliary Cancers

Cases from the Community: Integrating New Research Findings into Current Practice — Hepatobiliary Cancers

2024-12-1855:50

Cases from the Community: Integrating New Research Findings into Current Practice — Gynecologic Cancers

Cases from the Community: Integrating New Research Findings into Current Practice — Gynecologic Cancers

2024-12-1746:41

Cases from the Community: Integrating New Research Findings into Current Practice — Myelofibrosis

Cases from the Community: Integrating New Research Findings into Current Practice — Myelofibrosis

2024-12-1751:43

Cases from the Community: Integrating New Research Findings into Current Practice — Leukemia and Myelodysplastic Syndromes

Cases from the Community: Integrating New Research Findings into Current Practice — Leukemia and Myelodysplastic Syndromes

2024-12-1351:45

Cases from the Community: Integrating New Research Findings into Current Practice — Lung Cancer

Cases from the Community: Integrating New Research Findings into Current Practice — Lung Cancer

2024-12-1348:03

5-Minute Journal Club Issue 2 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

5-Minute Journal Club Issue 2 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

2024-12-1311:59

Meet The Professor: Current and Future Use of Nontargeted Therapy for Metastatic Non-Small Cell Lung Cancer — A 2024 World Conference on Lung Cancer Review

Meet The Professor: Current and Future Use of Nontargeted Therapy for Metastatic Non-Small Cell Lung Cancer — A 2024 World Conference on Lung Cancer Review

2024-12-1058:47

Exploring the Current Management Paradigm for Patients with Metastatic Triple-Negative Breast Cancer

Exploring the Current Management Paradigm for Patients with Metastatic Triple-Negative Breast Cancer

2024-12-0459:42

loading
Google Play
Download from Google Play
Castbox
Download from App Store
usUnited States
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Data + Perspectives: Clinical Investigators Discuss the Role of CAR T-Cell Therapy for Patients with Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

Data + Perspectives: Clinical Investigators Discuss the Role of CAR T-Cell Therapy for Patients with Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

Research To Practice